Clinical Trial Monitoring Services
Monitoring your trial with confidence from site initiation to database lock
Clinical Trial Monitoring Services in India by Zenovel
At Zenovel, our Clinical Trial Monitoring Services team delivers fast, seamless, and effective investigator site support and data oversight throughout the study lifecycle. We have extensive expertise in monitoring Phase I–IV clinical trials, post-marketing surveillance, Real-World Evidence (RWE) studies, Specialist Cohort Event Monitoring (SCEM), and Health Economics and Outcomes Research (HEOR) studies.
Our Clinical Trial Monitoring Services include comprehensive Source Data Verification (SDV – 100%) and Risk-Based Monitoring (RBM), with a focus on identifying and escalating adverse events, conducting site initiation visits, routine and interim monitoring visits, close-out visits, and providing ongoing formal training programs to ensure study quality, compliance, and data integrity.
1. Onsite monitoring:
Modern trials require agility, transparency, and scientific rigor. Zenovel clinical research associates (CRAs) perform onsite visits to investigational study sites to evaluate facilities, documents, and trial processes, ensuring adherence to protocols, patient safety, and data integrity in accordance with GCP guidelines.
Our onsite CRM services involves:
- Pre-study visits: Assessing site suitability and investigator capabilities prior to the trial is crucial for success.
- Initiation Visit (SIV): Training site staff on protocols, data collection systems, and regulatory requirements is essential prior to patient enrollment.
- Routine Monitoring Visits: Ongoing visits or remote checks are conducted to verify compliance and address emerging issues.
- Close-Out Visit (COV): Study activities conclude with the return or destruction of investigational products and proper archiving of documents.
2. Remote monitoring:
We replace on-site traditional monitoring with real time data site methods. Our team implements off-site tracking of the clinical trial data and patient safety using digital plans. This ensure reduce trial costs, and logistic burden on sites and on participants.
We implement two methods centralized monitoring and risk based monitoring that assures cost efficiency, continuous oversight, and patient centricity.
Our remote monitoring services includes:
- Electronic data capture (EDC) & eSource: By using systems, CRAs can quickly review trial data, conduct remote SDV, and identify missing entries.
- Remote patient monitoring & wearables: We use devices that are continuously stream physiological data directly to researchers.
- Virtual communication: We conducts meetings, training, consulting and collaboration with the study staffs and PI through video conference and messaging platforms.
3. Risk based monitoring (RBM):
Risk-based monitoring services ensures the quality of clinical trials by identifying, assessing, monitoring, and mitigating risks that may impact study safety and quality. The US Food and Drug Administration (FDA) provides guidance outlining three steps in a risk-based monitoring approach.
- Centralized Oversight: Our team employs real-time data analytics and electronic systems to continuously detect signals and potential issues.
- Remote Monitoring: Our team conducts remote online monitoring with remote data reviews.
- Targeted On-Site Visits: Our team focuses on locations with triggered events or elevated risks instead of conducting 100% SDV at all sites.
- Why Zenovel is the best choice for Clinical Trial Monitoring services?
- Knowledgeable and experienced team
Our team has extensive experience in monitoring investigational sites, yielding positive results.
- Global Reach and Experience
- Our clinical trial monitors ensure GCP compliance effectively through their global reach, traveling across continents.
- System adaptation and adjustments
Technology has evolved significantly over decades, and we have continuously updated ourselves to adapt to these changes.
- AI driven environment
Our team is committed to gaining knowledge and hands-on experience in the AI-driven environment to ensure your trial is acceptable in this era.
People Also Ask (FAQs)
At Zenovel, we assign Clinical Research Associate or Clinical Trial Monitor to act as the primary link between the clinical trial site and sponsor
Regular site visits, document reviews, and follow-ups on patient check-ups and reported side effects are essential for ongoing evaluation.
Regular site visits, document reviews, and follow-ups on patient check-ups and reported side effects are essential for ongoing evaluation.
According to ICH-E6 guidelines, the sponsor must appoint qualified medical personnel, referred to as the Medical Monitor, to be available for trial-related medical queries. Their contact details are included in the trial protocol.
Risk-based monitoring optimizes resource allocation in clinical trials by targeting high-risk areas and critical data points, enhancing efficiency through a focused risk assessment.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
